skip to content

Yusuf Hamied Department of Chemistry

 
Read more at: Conversations on Chemistry: watch Dr Peter Wothers alumni lecture
A man in a suit speaks at a lecturn

Conversations on Chemistry: watch Dr Peter Wothers alumni lecture

Dr Peter Wothers presentation 11th Feb 2023 taken by Michael Webb ©University of Cambridge

Dr Peter Wothers gave a fascinating talk on pioneering science writer Jane Marcet at our annual alumni lecture on 11 February,


Read more at: New gift for Alzheimer’s disease research
Six people stand in front of a glass plaque

New gift for Alzheimer’s disease research

Chemistry of Health opening ceremony, Nathan Pitt, University of Cambridge.

Mr R. Derek Finlay (Emmanuel 1952) has given another £2 million to promote further innovation in the Department’s Centre for Misfolding Diseases (CMD), located in our Chemistry of Health building.


Read more at: The women in neuroscience network and its student founder
A woman in a purple tshirt in light spacious hall

The women in neuroscience network and its student founder

Elizabeth ‘Lizzie’ English wanted to connect with other women in neuroscience but couldn’t find quite the right organisation. So she started the Women in Neuroscience Network in the UK.


Read more at: Chemistry Spin-out creates better sequencing method
stylized image of DNA

Chemistry Spin-out creates better sequencing method

Image of DNA courtesy Epigenetix

Researchers at Balasubramanian Group spin-out Cambridge Epigenetix have found a new way to sequence genetic and epigenetic information in the same work flow, which could help detect diseases like cancer.


Read more at: European Research Council consolidator grant for organic chemistry
A man in a lab coat writes on a glass fume hood.

European Research Council consolidator grant for organic chemistry

Robert Phipps during graduate open day 2017, Nathan Pitt, ©University of Cambridge

Professor Robert Phipps has been awarded a European Research Council consolidator grant for research into enantioselective radical chemistry.


Read more at: Grant awarded to research high performance and long-life fast charging batteries for electric vehicles
A man sits at a desk with two monitors.

Grant awarded to research high performance and long-life fast charging batteries for electric vehicles

Dr Israel Temprano in his lab, Gabriella Bocchetti©University of Cambridge

“We will be working to advance the performance of fast charging, long life batteries for automotive,” explains Dr Israel Temprano, who has received a grant as part of a collaboration to research ultra-fast charging batteries.


Read more at: Biodesign: DNA-inspired architecture to treat cancer
Woman gives a presentation.

Biodesign: DNA-inspired architecture to treat cancer

Professor Hanadi Sleiman leads the 2023 Cambridge Energy Transition Lecture, Nathan Pitt, University of Cambridge.

Professor Hanadi Sleiman spoke on her work on DNA nanostructures and how they can be applied to drug design and delivery at the 2023 Cambridge Energy Transition Lecture here in January.


Read more at: Early career researcher recognised for her antibody research
Yanira Mendez Gomez smiling at camera in lab

Early career researcher recognised for her antibody research

Courtesy @Chemistry

Bernardes Group researcher Dr Yanira Méndez Gómez has won the Otto Bayer Early Excellence in Science Award.


Read more at: New ice is like a snapshot of liquid water
Ice and ball bearings in a metal cup.

New ice is like a snapshot of liquid water

Part of the setup for creating medium density amorphous ice, Christoph Salzmann

A collaboration between scientists at Cambridge and UCL has led to the discovery of a new form of ice that more closely resembles liquid water than any other and may hold the key to understanding this most famous of liquids.


Read more at: Cambridge Oncology: the start up rethinking cancer therapy
Two people sit on garden steps

Cambridge Oncology: the start up rethinking cancer therapy

Melinda Duer and James Harrison at Robinson College taken by Nathan Pitt, ©University of Cambridge

Cambridge Oncology, a new company co-founded by Professor Melinda Duer and James Harrison, CEO of Cycle Pharmaceuticals, is pioneering a new drug that combats cancer tumours by targeting their environment.